[(2S,3R,4S,5R,6R)-6-[1-[(3S,12R,15Z,18R,21S,24S,25R)-24-[[2-[[3-[(2S,3S,4R,5R)-4-[(2R,3S,4S,5R,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-2-hydroxyhexadecanoyl]amino]-3-hydroxybutanoyl]amino]-12-(3-amino-3-oxopropyl)-15-ethylidene-21-[(1S)-1-hydroxyethyl]-3,18-bis[(4-hydroxyphenyl)methyl]-7,25-dimethyl-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-6-yl]ethoxy]-3-acetyloxy-4,5-dihydroxyoxan-2-yl]methyl acetate

Details

Top
Internal ID 9b05b454-4043-4589-928d-b94767b820c6
Taxonomy Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides > Cyclic glycodepsipeptides
IUPAC Name [(2S,3R,4S,5R,6R)-6-[1-[(3S,12R,15Z,18R,21S,24S,25R)-24-[[2-[[3-[(2S,3S,4R,5R)-4-[(2R,3S,4S,5R,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-2-hydroxyhexadecanoyl]amino]-3-hydroxybutanoyl]amino]-12-(3-amino-3-oxopropyl)-15-ethylidene-21-[(1S)-1-hydroxyethyl]-3,18-bis[(4-hydroxyphenyl)methyl]-7,25-dimethyl-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-6-yl]ethoxy]-3-acetyloxy-4,5-dihydroxyoxan-2-yl]methyl acetate
SMILES (Canonical) CCCCCCCCCCCCCC(C(C(=O)NC(C(C)O)C(=O)NC1C(OC(=O)C(NC(=O)C(N(C(=O)CNC(=O)C(NC(=O)C(=CC)NC(=O)C(NC(=O)C(NC1=O)C(C)O)CC2=CC=C(C=C2)O)CCC(=O)N)C)C(C)OC3C(C(C(C(O3)COC(=O)C)OC(=O)C)O)O)CC4=CC=C(C=C4)O)C)O)OC5C(C(C(CO5)O)OC6C(C(C(C(O6)CO)O)O)NC(=O)C)O
SMILES (Isomeric) CCCCCCCCCCCCCC(C(C(=O)NC(C(C)O)C(=O)N[C@H]1[C@H](OC(=O)[C@@H](NC(=O)C(N(C(=O)CNC(=O)[C@H](NC(=O)/C(=C/C)/NC(=O)[C@H](NC(=O)[C@@H](NC1=O)[C@H](C)O)CC2=CC=C(C=C2)O)CCC(=O)N)C)C(C)O[C@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)COC(=O)C)OC(=O)C)O)O)CC4=CC=C(C=C4)O)C)O)O[C@H]5[C@H]([C@@H]([C@@H](CO5)O)O[C@@H]6[C@H]([C@@H]([C@H]([C@@H](O6)CO)O)O)NC(=O)C)O
InChI InChI=1S/C85H129N11O35/c1-11-13-14-15-16-17-18-19-20-21-22-23-56(128-84-71(113)72(55(105)38-124-84)131-83-64(88-44(7)100)68(110)66(108)57(37-97)129-83)67(109)81(121)94-62(41(4)99)78(118)95-63-42(5)125-82(122)54(35-48-26-30-50(104)31-27-48)92-80(120)65(43(6)126-85-70(112)69(111)73(127-46(9)102)58(130-85)39-123-45(8)101)96(10)60(107)36-87-74(114)52(32-33-59(86)106)90-75(115)51(12-2)89-76(116)53(34-47-24-28-49(103)29-25-47)91-77(117)61(40(3)98)93-79(63)119/h12,24-31,40-43,52-58,61-73,83-85,97-99,103-105,108-113H,11,13-23,32-39H2,1-10H3,(H2,86,106)(H,87,114)(H,88,100)(H,89,116)(H,90,115)(H,91,117)(H,92,120)(H,93,119)(H,94,121)(H,95,118)/b51-12-/t40-,41?,42+,43?,52+,53+,54-,55+,56?,57-,58-,61-,62?,63-,64-,65?,66-,67?,68-,69-,70+,71-,72+,73-,83+,84-,85+/m0/s1
InChI Key YKABXFYFYDWAFN-TWYLKZDQSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C85H129N11O35
Molecular Weight 1865.00 g/mol
Exact Mass 1863.8652548 g/mol
Topological Polar Surface Area (TPSA) 702.00 Ų
XlogP -0.20
Atomic LogP (AlogP) -6.07
H-Bond Acceptor 35
H-Bond Donor 22
Rotatable Bonds 38

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3R,4S,5R,6R)-6-[1-[(3S,12R,15Z,18R,21S,24S,25R)-24-[[2-[[3-[(2S,3S,4R,5R)-4-[(2R,3S,4S,5R,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-2-hydroxyhexadecanoyl]amino]-3-hydroxybutanoyl]amino]-12-(3-amino-3-oxopropyl)-15-ethylidene-21-[(1S)-1-hydroxyethyl]-3,18-bis[(4-hydroxyphenyl)methyl]-7,25-dimethyl-2,5,8,11,14,17,20,23-octaoxo-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-6-yl]ethoxy]-3-acetyloxy-4,5-dihydroxyoxan-2-yl]methyl acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.7669 76.69%
Caco-2 - 0.8573 85.73%
Blood Brain Barrier - 0.9500 95.00%
Human oral bioavailability - 0.7571 75.71%
Subcellular localzation Mitochondria 0.4243 42.43%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.7896 78.96%
OATP1B3 inhibitior + 0.9185 91.85%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior + 0.9628 96.28%
P-glycoprotein inhibitior + 0.7417 74.17%
P-glycoprotein substrate + 0.8721 87.21%
CYP3A4 substrate + 0.7640 76.40%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8704 87.04%
CYP3A4 inhibition + 0.5066 50.66%
CYP2C9 inhibition - 0.8211 82.11%
CYP2C19 inhibition - 0.9061 90.61%
CYP2D6 inhibition - 0.8200 82.00%
CYP1A2 inhibition - 0.8897 88.97%
CYP2C8 inhibition + 0.8583 85.83%
CYP inhibitory promiscuity - 0.9493 94.93%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9000 90.00%
Carcinogenicity (trinary) Non-required 0.5685 56.85%
Eye corrosion - 0.9860 98.60%
Eye irritation - 0.8952 89.52%
Skin irritation - 0.7624 76.24%
Skin corrosion - 0.9289 92.89%
Ames mutagenesis - 0.5956 59.56%
Human Ether-a-go-go-Related Gene inhibition + 0.7368 73.68%
Micronuclear + 0.8900 89.00%
Hepatotoxicity - 0.6391 63.91%
skin sensitisation - 0.8756 87.56%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.9111 91.11%
Mitochondrial toxicity + 0.8875 88.75%
Nephrotoxicity - 0.7272 72.72%
Acute Oral Toxicity (c) III 0.6485 64.85%
Estrogen receptor binding - 0.5222 52.22%
Androgen receptor binding + 0.7589 75.89%
Thyroid receptor binding + 0.8074 80.74%
Glucocorticoid receptor binding + 0.8439 84.39%
Aromatase binding + 0.8077 80.77%
PPAR gamma + 0.7811 78.11%
Honey bee toxicity - 0.5988 59.88%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.5702 57.02%
Fish aquatic toxicity + 0.8934 89.34%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 99.85% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 99.71% 83.82%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.69% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.59% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 98.93% 94.45%
CHEMBL2107 P61073 C-X-C chemokine receptor type 4 98.77% 93.10%
CHEMBL226 P30542 Adenosine A1 receptor 97.87% 95.93%
CHEMBL5103 Q969S8 Histone deacetylase 10 97.84% 90.08%
CHEMBL3837 P07711 Cathepsin L 97.56% 96.61%
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.53% 97.25%
CHEMBL3060 Q9Y345 Glycine transporter 2 96.90% 99.17%
CHEMBL2345 P51812 Ribosomal protein S6 kinase alpha 3 96.06% 95.64%
CHEMBL255 P29275 Adenosine A2b receptor 95.86% 98.59%
CHEMBL1806 P11388 DNA topoisomerase II alpha 95.74% 89.00%
CHEMBL2563 Q9UQL6 Histone deacetylase 5 95.74% 89.67%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 95.36% 92.86%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 94.86% 100.00%
CHEMBL2996 Q05655 Protein kinase C delta 94.84% 97.79%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 94.48% 95.17%
CHEMBL5608 Q16288 NT-3 growth factor receptor 94.12% 95.89%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 93.55% 96.90%
CHEMBL5469 Q14289 Protein tyrosine kinase 2 beta 93.45% 91.03%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 92.67% 95.83%
CHEMBL3359 P21462 Formyl peptide receptor 1 92.28% 93.56%
CHEMBL2514 O95665 Neurotensin receptor 2 91.69% 100.00%
CHEMBL4588 P22894 Matrix metalloproteinase 8 91.56% 94.66%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 91.31% 93.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.04% 95.56%
CHEMBL2069156 Q14145 Kelch-like ECH-associated protein 1 90.85% 82.38%
CHEMBL5852 Q96P65 Pyroglutamylated RFamide peptide receptor 90.15% 85.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.53% 97.09%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 89.35% 95.50%
CHEMBL2693 Q9UIQ6 Cystinyl aminopeptidase 89.14% 97.64%
CHEMBL1937 Q92769 Histone deacetylase 2 89.09% 94.75%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 89.00% 95.89%
CHEMBL299 P17252 Protein kinase C alpha 88.80% 98.03%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 88.54% 97.29%
CHEMBL215 P09917 Arachidonate 5-lipoxygenase 88.31% 92.68%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.17% 86.33%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 87.69% 97.14%
CHEMBL4227 P25090 Lipoxin A4 receptor 87.48% 100.00%
CHEMBL3392948 Q9NP59 Solute carrier family 40 member 1 87.39% 95.00%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 87.18% 94.33%
CHEMBL3038469 P24941 CDK2/Cyclin A 87.01% 91.38%
CHEMBL3045 P05771 Protein kinase C beta 86.94% 97.63%
CHEMBL5043 Q6P179 Endoplasmic reticulum aminopeptidase 2 86.21% 91.81%
CHEMBL2413 P32246 C-C chemokine receptor type 1 86.13% 89.50%
CHEMBL3130 O00329 PI3-kinase p110-delta subunit 85.73% 96.47%
CHEMBL2094135 Q96BI3 Gamma-secretase 85.43% 98.05%
CHEMBL3891 P07384 Calpain 1 85.41% 93.04%
CHEMBL3401 O75469 Pregnane X receptor 85.38% 94.73%
CHEMBL5555 O00767 Acyl-CoA desaturase 84.30% 97.50%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.16% 85.14%
CHEMBL5255 O00206 Toll-like receptor 4 82.72% 92.50%
CHEMBL3310 Q96DB2 Histone deacetylase 11 82.36% 88.56%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 82.34% 92.88%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 82.16% 95.50%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 81.52% 91.24%
CHEMBL2492 P36544 Neuronal acetylcholine receptor protein alpha-7 subunit 81.34% 88.42%
CHEMBL4769 O95749 Geranylgeranyl pyrophosphate synthetase 81.28% 92.08%
CHEMBL4071 P08311 Cathepsin G 81.18% 94.64%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 163115781
LOTUS LTS0208673
wikiData Q105349571